Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3 participants
OBSERVATIONAL
2018-11-05
2020-11-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brugada Syndrome Substrate Characterization and Ablation
NCT05643209
Feasibility of Improving Risk Stratification in Brugada Syndrome
NCT03992677
Unmasking Concealed Arrhythmia Syndromes
NCT06988189
High Density Mapping in Brugada Syndrome
NCT06567639
AnalyST & Brugada Syndrome - Feasibility Study
NCT02052765
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients able and willing to give their written informed consent.
* Planned PCI of a CTO of a right coronary artery
* Planned use of an anchor balloon in the Conus branch or RV branch
Exclusion Criteria
* Patients with a pre-existing, confirmed or possible diagnosis of Brugada Syndrome
* Marked ST elevation or J point elevation on baseline (prior to procedure) ECG in the precordial leads (V1-V3)
* Pregnancy. This will be tested by urine HcG measurement
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barts & The London NHS Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pier Lambiase, PhD FRCP FHRS
Role: PRINCIPAL_INVESTIGATOR
Barts & The London NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Barts Health NHS Trust
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Version 1 08/12/2016
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.